Table 3. Significant genetic correlation across covariate-adjusted organohalogen serum levels and corresponding linear correlation.
Maternal Genetics | Fetal Genetics | M/F rg | |||||||
---|---|---|---|---|---|---|---|---|---|
Compound | Compound | N | rg (SE) | rres | rg ≠ rres Pa | N | rg (SE) | P-Valuea | Mrg ≠ Frg Pb |
BDE-28 | BDE-100 | 698 | 0.92*** (0.08) | 0.77*** | <0.01 | 649 | NC | ND | ND |
BDE-28 | BDE-153 | 697 | 0.34*** (0.29) | 0.56*** | 2.1 × 10−7 | 648 | 0.66*** (0.21) | 3.4 × 10−3 | 1.1 × 10−15 |
BDE-47 | BDE-99 | 741 | 0.98*** (0.04) | 0.93*** | <0.01 | 688 | NC | ND | ND |
BDE-47 | BDE-100 | 750 | 1.00*** (0.04) | 0.93*** | <0.01 | 697 | NC | ND | ND |
BDE-47 | BDE-153 | 749 | 0.61* (0.18) | 0.65*** | NS | 696 | 0.77*** (0.09) | 3.4 × 10−6 | 3.6 × 10−9 |
BDE-99 | BDE-100 | 741 | 0.99*** (0.07) | 0.88*** | <0.01 | 688 | NC | ND | ND |
BDE-99 | BDE-153 | 740 | 0.34*** (0.31) | 0.60*** | 9.7 × 10−12 | 687 | 0.66*** (0.22) | NS | 2.2 × 10−16 |
BDE-100 | BDE-153 | 749 | 0.64*** (0.16) | 0.82*** | 1.4 × 10−14 | 696 | NC | ND | ND |
PCB180 | PCB138/158 | 752 | 1.00*** (0.40) | 0.81*** | <0.01 | 698 | NC | ND | ND |
PCB180 | PCB187 | 714 | 0.80*** (0.33) | 0.86*** | 2.4 × 10−4 | 664 | NC | ND | ND |
rg, genetic correlation; SE, standard error; rres, significant Spearman’s linear correlation across residual congener levels after covariate adjustment; P, P-value; M/F, maternal/fetal; NS, not significant; NC, not converged; ND, not done. *** P < 0.001, ** P < 0.01, * P < 0.05.
Fisher’s z transformation test between residual and genetic correlation coefficients.
Fisher’s z transformation test between maternal genetic and fetal genetic correlation coefficients.